TY - JOUR AU - Gershenwald, J. AU - Scolyer, R. PY - 2018 DA - 2018// TI - Melanoma staging: American joint committee on Cancer (AJCC) 8th edition and beyond JO - Ann Surg Oncol VL - 25 UR - https://doi.org/10.1245/s10434-018-6513-7 DO - 10.1245/s10434-018-6513-7 ID - Gershenwald2018 ER - TY - JOUR AU - Albertini, M. PY - 2018 DA - 2018// TI - The age of enlightenment in melanoma immunotherapy JO - J Immunother Cancer VL - 6 UR - https://doi.org/10.1186/s40425-018-0397-8 DO - 10.1186/s40425-018-0397-8 ID - Albertini2018 ER - TY - JOUR AU - Skowron, F. AU - Berard, F. AU - Balme, B. AU - Maucort-Boulch, D. PY - 2015 DA - 2015// TI - Role of obesity on the thickness of primary cutaneous melanoma JO - J Eur Acad Dermatol Venerol VL - 29 UR - https://doi.org/10.1111/jdv.12515 DO - 10.1111/jdv.12515 ID - Skowron2015 ER - TY - JOUR AU - Sergentanis, T. N. AU - Antoniadis, A. G. AU - Gogas, H. J. PY - 2013 DA - 2013// TI - Obesity and risk of malignant melanoma: a meta-analysis of cohort and case-control studies JO - Eur J Cancer VL - 49 UR - https://doi.org/10.1016/j.ejca.2012.08.028 DO - 10.1016/j.ejca.2012.08.028 ID - Sergentanis2013 ER - TY - JOUR AU - McQuade, J. AU - Daniel, C. PY - 2018 DA - 2018// TI - Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis JO - Lancet Oncol VL - 19 UR - https://doi.org/10.1016/S1470-2045(18)30078-0 DO - 10.1016/S1470-2045(18)30078-0 ID - McQuade2018 ER - TY - JOUR AU - Wang, Z. AU - Aguilar, E. AU - Luna, J. PY - 2019 DA - 2019// TI - Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade JO - Nat Med VL - 25 UR - https://doi.org/10.1038/s41591-018-0221-5 DO - 10.1038/s41591-018-0221-5 ID - Wang2019 ER - TY - JOUR AU - Cortellini, A. PY - 2019 DA - 2019// TI - A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable JO - J Immunother Cancer VL - 7 UR - https://doi.org/10.1186/s40425-019-0527-y DO - 10.1186/s40425-019-0527-y ID - Cortellini2019 ER - TY - JOUR AU - Naik, G. PY - 2019 DA - 2019// TI - Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition JO - J Immunother Cancer VL - 7 UR - https://doi.org/10.1186/s40425-019-0512-5 DO - 10.1186/s40425-019-0512-5 ID - Naik2019 ER - TY - JOUR AU - Richtig, G. PY - 2018 DA - 2018// TI - Body mass index may predict the response to ipilimumab in metastatic melanoma: an observational multi-Centre study JO - PLoS One VL - 13 UR - https://doi.org/10.1371/journal.pone.0204729 DO - 10.1371/journal.pone.0204729 ID - Richtig2018 ER - TY - JOUR AU - Rassy, E. E. PY - 2018 DA - 2018// TI - Do immune checkpoint inhibitors perform identically in patients with weight extremes? JO - Immunotherapy VL - 10 UR - https://doi.org/10.2217/imt-2018-0053 DO - 10.2217/imt-2018-0053 ID - Rassy2018 ER - TY - JOUR AU - Dirks, N. L. AU - Meibohm, B. PY - 2010 DA - 2010// TI - Population pharmacokinetics of therapeutic monoclonal antibodies JO - Clin Pharmacokinet VL - 49 UR - https://doi.org/10.2165/11535960-000000000-00000 DO - 10.2165/11535960-000000000-00000 ID - Dirks2010 ER - TY - JOUR AU - Jung, U. AU - Choi, M. PY - 2014 DA - 2014// TI - Obesity and its metabolic complications: the role of Adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease JO - Int J Mol Sci VL - 15 UR - https://doi.org/10.3390/ijms15046184 DO - 10.3390/ijms15046184 ID - Jung2014 ER - TY - JOUR AU - Ahamadi, M. PY - 2017 DA - 2017// TI - Model-based characterization of the pharmacokinetics of Pembrolizumab: a humanized anti-PD-1 monoclonal antibody in advanced solid tumors JO - CPT Pharmacometrics Syst Pharmacol VL - 6 UR - https://doi.org/10.1002/psp4.12139 DO - 10.1002/psp4.12139 ID - Ahamadi2017 ER - TY - JOUR AU - Wolchok, J. PY - 2017 DA - 2017// TI - Overall survival with combined Nivolumab and Ipilimumab in advanced melanoma JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1709684 DO - 10.1056/NEJMoa1709684 ID - Wolchok2017 ER - TY - JOUR AU - Pulte, D. PY - 2019 DA - 2019// TI - Changes in population-level survival for advanced solid malignancies with new treatment options in the second decade of the 21st century JO - Cancer VL - 125 ID - Pulte2019 ER - TY - JOUR AU - Garg, S. K. AU - Maurer, H. AU - Reed, K. AU - Selagamsetty, R. PY - 2014 DA - 2014// TI - Diabetes and cancer: two diseases with obesity as a common risk factor JO - Diabetes Obes Metab VL - 16 UR - https://doi.org/10.1111/dom.12124 DO - 10.1111/dom.12124 ID - Garg2014 ER - TY - JOUR AU - Hall, J. PY - 2003 DA - 2003// TI - The kidney, hypertension, and obesity JO - Hypertension VL - 41 UR - https://doi.org/10.1161/01.HYP.0000052314.95497.78 DO - 10.1161/01.HYP.0000052314.95497.78 ID - Hall2003 ER -